Real-time enrollment status for this hepatocellular carcinoma (hcc) clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 12:20 AM UTC
| NCT Number | NCT07689175 |
| Recruiting Status | Recruiting |
| Condition | Hepatocellular Carcinoma (HCC) |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Texas Southwestern Medical Center |
| Last Updated on CT.gov | August 25, 2026 (Aug 25, 2026) |
As of October 17, 2026: Clinical trial NCT07689175 is currently recruiting participants. This phase2 study for hepatocellular carcinoma (hcc) is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Texas Southwestern Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07689175 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07689175 was last updated Aug 25, 2026 (August 25, 2026). HelloStudys verifies this status automatically.